0
U.S. (TOLL FREE)
+1 (315) 215-3225
Automative

0
U.S. (TOLL FREE)
+1 (315) 215-3225
Global Contact-Activated Lancet Market Research Report 2025
Published Date: September 2025
|
Report Code: QYRE-Auto-32M16486
Home | Market Reports | Health| Nutrition| Vitamins & Supplements
Global Contact Activated Lancet Market Research Report 2024
BUY CHAPTERS

Global Contact-Activated Lancet Market Research Report 2025

Code: QYRE-Auto-32M16486
Report
September 2025
Pages:94
QYResearch
Buy Now with 15% Discount
DESCRIPTION
TABLE OF CONTENT
TABLES & FIGURES

Contact-Activated Lancet Market

The global market for Contact-Activated Lancet was valued at US$ million in the year 2024 and is projected to reach a revised size of US$ million by 2031, growing at a CAGR of %during the forecast period.
Contact-activated lancets, also called finger sticks, are done using a device called a lancet. Lancets are needles or narrow, sharp blades that poke a small hole in the skin.
North American market for Contact-Activated Lancet is estimated to increase from $ million in 2024 to reach $ million by 2031, at a CAGR of % during the forecast period of 2025 through 2031.
Asia-Pacific market for Contact-Activated Lancet is estimated to increase from $ million in 2024 to reach $ million by 2031, at a CAGR of % during the forecast period of 2025 through 2031.
The major global manufacturers of Contact-Activated Lancet include BD, Accu-Chek (Roche), OneTouch (LifeScan), FreeStyle (Abbott), Microlet Next (Ascensia), Terumo, Genteel, CareTouch, Pip Diabetes Care, Owen Mumford, etc. In 2024, the world's top three vendors accounted for approximately % of the revenue.

Report Scope

This report aims to provide a comprehensive presentation of the global market for Contact-Activated Lancet, with both quantitative and qualitative analysis, to help readers develop business/growth strategies, assess the market competitive situation, analyze their position in the current marketplace, and make informed business decisions regarding Contact-Activated Lancet.
The Contact-Activated Lancet market size, estimations, and forecasts are provided in terms of sales volume (K Units) and revenue ($ millions), considering 2024 as the base year, with history and forecast data for the period from 2020 to 2031. This report segments the global Contact-Activated Lancet market comprehensively. Regional market sizes, concerning products by Type, by Application, and by players, are also provided.
For a more in-depth understanding of the market, the report provides profiles of the competitive landscape, key competitors, and their respective market ranks. The report also discusses technological trends and new product developments.
The report will help the Contact-Activated Lancet manufacturers, new entrants, and industry chain related companies in this market with information on the revenues, sales volume, and average price for the overall market and the sub-segments across the different segments, by company, by Type, by Application, and by regions.

Scope of Contact-Activated Lancet Market Report

Report Metric Details
Report Name Contact-Activated Lancet Market
Segment by Type
  • Below 30G
  • Above 30G
Segment by Application
  • Hospital
  • Clinic
  • Others
Consumption by Region
  • North America (United States, Canada)
  • Europe (Germany, France, UK, Italy, Russia)
  • Asia-Pacific (China, Japan, South Korea, Taiwan)
  • Southeast Asia (India)
  • Latin America (Mexico, Brazil)
By Company BD, Accu-Chek (Roche), OneTouch (LifeScan), FreeStyle (Abbott), Microlet Next (Ascensia), Terumo, Genteel, CareTouch, Pip Diabetes Care, Owen Mumford, Trividia Health, AUVON
Forecast units USD million in value
Report coverage Revenue and volume forecast, company share, competitive landscape, growth factors and trends

Core Chapters

  • Chapter 1: Introduces the report scope of the report, executive summary of different market segments (by region, product type, application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
  • Chapter 2: Detailed analysis of Contact-Activated Lancet manufacturers competitive landscape, price, sales and revenue market share, latest development plan, merger, and acquisition information, etc.
  • Chapter 3: Sales, revenue of Contact-Activated Lancet in regional level and country level. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and market size of each country in the world.
  • Chapter 4: Provides the analysis of various market segments by Type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
  • Chapter 5: Provides the analysis of various market segments by Application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
  • Chapter 6: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.
  • Chapter 7: Analysis of industrial chain, including the upstream and downstream of the industry.
  • Chapter 8: Introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.
  • Chapter 9: The main points and conclusions of the report. 

FAQ for this report

Who are the main players in the Contact-Activated Lancet Market report?

Ans: The main players in the Contact-Activated Lancet Market are BD, Accu-Chek (Roche), OneTouch (LifeScan), FreeStyle (Abbott), Microlet Next (Ascensia), Terumo, Genteel, CareTouch, Pip Diabetes Care, Owen Mumford, Trividia Health, AUVON

What are the Application segmentation covered in the Contact-Activated Lancet Market report?

Ans: The Applications covered in the Contact-Activated Lancet Market report are Hospital, Clinic, Others

What are the Type segmentation covered in the Contact-Activated Lancet Market report?

Ans: The Types covered in the Contact-Activated Lancet Market report are Below 30G, Above 30G

1 Contact-Activated Lancet Market Overview
1.1 Product Definition
1.2 Contact-Activated Lancet by Type
1.2.1 Global Contact-Activated Lancet Market Value Comparison by Type (2024 VS 2031)
1.2.2 Below 30G
1.2.3 Above 30G
1.3 Contact-Activated Lancet by Application
1.3.1 Global Contact-Activated Lancet Market Value by Application (2024 VS 2031)
1.3.2 Hospital
1.3.3 Clinic
1.3.4 Others
1.4 Global Contact-Activated Lancet Market Size Estimates and Forecasts
1.4.1 Global Contact-Activated Lancet Revenue 2020-2031
1.4.2 Global Contact-Activated Lancet Sales 2020-2031
1.4.3 Global Contact-Activated Lancet Market Average Price (2020-2031)
1.5 Assumptions and Limitations
2 Contact-Activated Lancet Market Competition by Manufacturers
2.1 Global Contact-Activated Lancet Sales Market Share by Manufacturers (2020-2025)
2.2 Global Contact-Activated Lancet Revenue Market Share by Manufacturers (2020-2025)
2.3 Global Contact-Activated Lancet Average Price by Manufacturers (2020-2025)
2.4 Global Key Players of Contact-Activated Lancet, Industry Ranking, 2022 VS 2023 VS 2024
2.5 Global Key Manufacturers of Contact-Activated Lancet, Manufacturing Sites & Headquarters
2.6 Global Key Manufacturers of Contact-Activated Lancet, Product Type & Application
2.7 Global Key Manufacturers of Contact-Activated Lancet, Date of Enter into This Industry
2.8 Global Contact-Activated Lancet Market Competitive Situation and Trends
2.8.1 Global Contact-Activated Lancet Market Concentration Rate
2.8.2 The Global 5 and 10 Largest Contact-Activated Lancet Players Market Share by Revenue
2.8.3 Global Contact-Activated Lancet Market Share by Company Type (Tier 1, Tier 2, and Tier 3)
2.9 Manufacturers Mergers & Acquisitions, Expansion Plans
3 Global Contact-Activated Lancet Market Scenario by Region
3.1 Global Contact-Activated Lancet Market Size by Region: 2020 Versus 2024 Versus 2031
3.2 Global Contact-Activated Lancet Sales by Region: 2020-2031
3.2.1 Global Contact-Activated Lancet Sales by Region: 2020-2025
3.2.2 Global Contact-Activated Lancet Sales by Region: 2026-2031
3.3 Global Contact-Activated Lancet Revenue by Region: 2020-2031
3.3.1 Global Contact-Activated Lancet Revenue by Region: 2020-2025
3.3.2 Global Contact-Activated Lancet Revenue by Region: 2026-2031
3.4 North America Contact-Activated Lancet Market Facts & Figures by Country
3.4.1 North America Contact-Activated Lancet Market Size by Country: 2020 VS 2024 VS 2031
3.4.2 North America Contact-Activated Lancet Sales by Country (2020-2031)
3.4.3 North America Contact-Activated Lancet Revenue by Country (2020-2031)
3.4.4 United States
3.4.5 Canada
3.5 Europe Contact-Activated Lancet Market Facts & Figures by Country
3.5.1 Europe Contact-Activated Lancet Market Size by Country: 2020 VS 2024 VS 2031
3.5.2 Europe Contact-Activated Lancet Sales by Country (2020-2031)
3.5.3 Europe Contact-Activated Lancet Revenue by Country (2020-2031)
3.5.4 Germany
3.5.5 France
3.5.6 U.K.
3.5.7 Italy
3.5.8 Russia
3.6 Asia Pacific Contact-Activated Lancet Market Facts & Figures by Region
3.6.1 Asia Pacific Contact-Activated Lancet Market Size by Region: 2020 VS 2024 VS 2031
3.6.2 Asia Pacific Contact-Activated Lancet Sales by Region (2020-2031)
3.6.3 Asia Pacific Contact-Activated Lancet Revenue by Region (2020-2031)
3.6.4 China
3.6.5 Japan
3.6.6 South Korea
3.6.7 India
3.6.8 Australia
3.6.9 China Taiwan
3.6.10 Southeast Asia
3.7 Latin America Contact-Activated Lancet Market Facts & Figures by Country
3.7.1 Latin America Contact-Activated Lancet Market Size by Country: 2020 VS 2024 VS 2031
3.7.2 Latin America Contact-Activated Lancet Sales by Country (2020-2031)
3.7.3 Latin America Contact-Activated Lancet Revenue by Country (2020-2031)
3.7.4 Mexico
3.7.5 Brazil
3.7.6 Argentina
3.8 Middle East and Africa Contact-Activated Lancet Market Facts & Figures by Country
3.8.1 Middle East and Africa Contact-Activated Lancet Market Size by Country: 2020 VS 2024 VS 2031
3.8.2 Middle East and Africa Contact-Activated Lancet Sales by Country (2020-2031)
3.8.3 Middle East and Africa Contact-Activated Lancet Revenue by Country (2020-2031)
3.8.4 Turkey
3.8.5 Saudi Arabia
3.8.6 UAE
4 Segment by Type
4.1 Global Contact-Activated Lancet Sales by Type (2020-2031)
4.1.1 Global Contact-Activated Lancet Sales by Type (2020-2025)
4.1.2 Global Contact-Activated Lancet Sales by Type (2026-2031)
4.1.3 Global Contact-Activated Lancet Sales Market Share by Type (2020-2031)
4.2 Global Contact-Activated Lancet Revenue by Type (2020-2031)
4.2.1 Global Contact-Activated Lancet Revenue by Type (2020-2025)
4.2.2 Global Contact-Activated Lancet Revenue by Type (2026-2031)
4.2.3 Global Contact-Activated Lancet Revenue Market Share by Type (2020-2031)
4.3 Global Contact-Activated Lancet Price by Type (2020-2031)
5 Segment by Application
5.1 Global Contact-Activated Lancet Sales by Application (2020-2031)
5.1.1 Global Contact-Activated Lancet Sales by Application (2020-2025)
5.1.2 Global Contact-Activated Lancet Sales by Application (2026-2031)
5.1.3 Global Contact-Activated Lancet Sales Market Share by Application (2020-2031)
5.2 Global Contact-Activated Lancet Revenue by Application (2020-2031)
5.2.1 Global Contact-Activated Lancet Revenue by Application (2020-2025)
5.2.2 Global Contact-Activated Lancet Revenue by Application (2026-2031)
5.2.3 Global Contact-Activated Lancet Revenue Market Share by Application (2020-2031)
5.3 Global Contact-Activated Lancet Price by Application (2020-2031)
6 Key Companies Profiled
6.1 BD
6.1.1 BD Company Information
6.1.2 BD Description and Business Overview
6.1.3 BD Contact-Activated Lancet Sales, Revenue and Gross Margin (2020-2025)
6.1.4 BD Contact-Activated Lancet Product Portfolio
6.1.5 BD Recent Developments/Updates
6.2 Accu-Chek (Roche)
6.2.1 Accu-Chek (Roche) Company Information
6.2.2 Accu-Chek (Roche) Description and Business Overview
6.2.3 Accu-Chek (Roche) Contact-Activated Lancet Sales, Revenue and Gross Margin (2020-2025)
6.2.4 Accu-Chek (Roche) Contact-Activated Lancet Product Portfolio
6.2.5 Accu-Chek (Roche) Recent Developments/Updates
6.3 OneTouch (LifeScan)
6.3.1 OneTouch (LifeScan) Company Information
6.3.2 OneTouch (LifeScan) Description and Business Overview
6.3.3 OneTouch (LifeScan) Contact-Activated Lancet Sales, Revenue and Gross Margin (2020-2025)
6.3.4 OneTouch (LifeScan) Contact-Activated Lancet Product Portfolio
6.3.5 OneTouch (LifeScan) Recent Developments/Updates
6.4 FreeStyle (Abbott)
6.4.1 FreeStyle (Abbott) Company Information
6.4.2 FreeStyle (Abbott) Description and Business Overview
6.4.3 FreeStyle (Abbott) Contact-Activated Lancet Sales, Revenue and Gross Margin (2020-2025)
6.4.4 FreeStyle (Abbott) Contact-Activated Lancet Product Portfolio
6.4.5 FreeStyle (Abbott) Recent Developments/Updates
6.5 Microlet Next (Ascensia)
6.5.1 Microlet Next (Ascensia) Company Information
6.5.2 Microlet Next (Ascensia) Description and Business Overview
6.5.3 Microlet Next (Ascensia) Contact-Activated Lancet Sales, Revenue and Gross Margin (2020-2025)
6.5.4 Microlet Next (Ascensia) Contact-Activated Lancet Product Portfolio
6.5.5 Microlet Next (Ascensia) Recent Developments/Updates
6.6 Terumo
6.6.1 Terumo Company Information
6.6.2 Terumo Description and Business Overview
6.6.3 Terumo Contact-Activated Lancet Sales, Revenue and Gross Margin (2020-2025)
6.6.4 Terumo Contact-Activated Lancet Product Portfolio
6.6.5 Terumo Recent Developments/Updates
6.7 Genteel
6.7.1 Genteel Company Information
6.7.2 Genteel Description and Business Overview
6.7.3 Genteel Contact-Activated Lancet Sales, Revenue and Gross Margin (2020-2025)
6.7.4 Genteel Contact-Activated Lancet Product Portfolio
6.7.5 Genteel Recent Developments/Updates
6.8 CareTouch
6.8.1 CareTouch Company Information
6.8.2 CareTouch Description and Business Overview
6.8.3 CareTouch Contact-Activated Lancet Sales, Revenue and Gross Margin (2020-2025)
6.8.4 CareTouch Contact-Activated Lancet Product Portfolio
6.8.5 CareTouch Recent Developments/Updates
6.9 Pip Diabetes Care
6.9.1 Pip Diabetes Care Company Information
6.9.2 Pip Diabetes Care Description and Business Overview
6.9.3 Pip Diabetes Care Contact-Activated Lancet Sales, Revenue and Gross Margin (2020-2025)
6.9.4 Pip Diabetes Care Contact-Activated Lancet Product Portfolio
6.9.5 Pip Diabetes Care Recent Developments/Updates
6.10 Owen Mumford
6.10.1 Owen Mumford Company Information
6.10.2 Owen Mumford Description and Business Overview
6.10.3 Owen Mumford Contact-Activated Lancet Sales, Revenue and Gross Margin (2020-2025)
6.10.4 Owen Mumford Contact-Activated Lancet Product Portfolio
6.10.5 Owen Mumford Recent Developments/Updates
6.11 Trividia Health
6.11.1 Trividia Health Company Information
6.11.2 Trividia Health Description and Business Overview
6.11.3 Trividia Health Contact-Activated Lancet Sales, Revenue and Gross Margin (2020-2025)
6.11.4 Trividia Health Contact-Activated Lancet Product Portfolio
6.11.5 Trividia Health Recent Developments/Updates
6.12 AUVON
6.12.1 AUVON Company Information
6.12.2 AUVON Description and Business Overview
6.12.3 AUVON Contact-Activated Lancet Sales, Revenue and Gross Margin (2020-2025)
6.12.4 AUVON Contact-Activated Lancet Product Portfolio
6.12.5 AUVON Recent Developments/Updates
7 Industry Chain and Sales Channels Analysis
7.1 Contact-Activated Lancet Industry Chain Analysis
7.2 Contact-Activated Lancet Raw Material Supply Analysis
7.2.1 Key Raw Materials
7.2.2 Raw Materials Key Suppliers
7.3 Contact-Activated Lancet Production Mode & Process Analysis
7.4 Contact-Activated Lancet Sales and Marketing
7.4.1 Contact-Activated Lancet Sales Channels
7.4.2 Contact-Activated Lancet Distributors
7.5 Contact-Activated Lancet Customer Analysis
8 Contact-Activated Lancet Market Dynamics
8.1 Contact-Activated Lancet Industry Trends
8.2 Contact-Activated Lancet Market Drivers
8.3 Contact-Activated Lancet Market Challenges
8.4 Contact-Activated Lancet Market Restraints
9 Research Findings and Conclusion
10 Methodology and Data Source
10.1 Methodology/Research Approach
10.1.1 Research Programs/Design
10.1.2 Market Size Estimation
10.1.3 Market Breakdown and Data Triangulation
10.2 Data Source
10.2.1 Secondary Sources
10.2.2 Primary Sources
10.3 Author List
10.4 Disclaimer
List of Tables
 Table 1. Global Contact-Activated Lancet Market Value Comparison by Type (2024 VS 2031) & (US$ Million)
 Table 2. Global Contact-Activated Lancet Market Value by Application (2024 VS 2031) & (US$ Million)
 Table 3. Global Contact-Activated Lancet Market Competitive Situation by Manufacturers in 2024
 Table 4. Global Contact-Activated Lancet Sales (K Units) of Key Manufacturers (2020-2025)
 Table 5. Global Contact-Activated Lancet Sales Market Share by Manufacturers (2020-2025)
 Table 6. Global Contact-Activated Lancet Revenue (US$ Million) by Manufacturers (2020-2025)
 Table 7. Global Contact-Activated Lancet Revenue Share by Manufacturers (2020-2025)
 Table 8. Global Market Contact-Activated Lancet Average Price (US$/Unit) of Key Manufacturers (2020-2025)
 Table 9. Global Key Players of Contact-Activated Lancet, Industry Ranking, 2022 VS 2023 VS 2024
 Table 10. Global Key Manufacturers of Contact-Activated Lancet, Manufacturing Sites & Headquarters
 Table 11. Global Key Manufacturers of Contact-Activated Lancet, Product Type & Application
 Table 12. Global Key Manufacturers of Contact-Activated Lancet, Date of Enter into This Industry
 Table 13. Global Manufacturers Market Concentration Ratio (CR5 and HHI)
 Table 14. Global Contact-Activated Lancet by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Contact-Activated Lancet as of 2024)
 Table 15. Manufacturers Mergers & Acquisitions, Expansion Plans
 Table 16. Global Contact-Activated Lancet Market Size by Region (US$ Million): 2020 VS 2024 VS 2031
 Table 17. Global Contact-Activated Lancet Sales by Region (2020-2025) & (K Units)
 Table 18. Global Contact-Activated Lancet Sales Market Share by Region (2020-2025)
 Table 19. Global Contact-Activated Lancet Sales by Region (2026-2031) & (K Units)
 Table 20. Global Contact-Activated Lancet Sales Market Share by Region (2026-2031)
 Table 21. Global Contact-Activated Lancet Revenue by Region (2020-2025) & (US$ Million)
 Table 22. Global Contact-Activated Lancet Revenue Market Share by Region (2020-2025)
 Table 23. Global Contact-Activated Lancet Revenue by Region (2026-2031) & (US$ Million)
 Table 24. Global Contact-Activated Lancet Revenue Market Share by Region (2026-2031)
 Table 25. North America Contact-Activated Lancet Revenue by Country: 2020 VS 2024 VS 2031 (US$ Million)
 Table 26. North America Contact-Activated Lancet Sales by Country (2020-2025) & (K Units)
 Table 27. North America Contact-Activated Lancet Sales by Country (2026-2031) & (K Units)
 Table 28. North America Contact-Activated Lancet Revenue by Country (2020-2025) & (US$ Million)
 Table 29. North America Contact-Activated Lancet Revenue by Country (2026-2031) & (US$ Million)
 Table 30. Europe Contact-Activated Lancet Revenue by Country: 2020 VS 2024 VS 2031 (US$ Million)
 Table 31. Europe Contact-Activated Lancet Sales by Country (2020-2025) & (K Units)
 Table 32. Europe Contact-Activated Lancet Sales by Country (2026-2031) & (K Units)
 Table 33. Europe Contact-Activated Lancet Revenue by Country (2020-2025) & (US$ Million)
 Table 34. Europe Contact-Activated Lancet Revenue by Country (2026-2031) & (US$ Million)
 Table 35. Asia Pacific Contact-Activated Lancet Revenue by Region: 2020 VS 2024 VS 2031 (US$ Million)
 Table 36. Asia Pacific Contact-Activated Lancet Sales by Region (2020-2025) & (K Units)
 Table 37. Asia Pacific Contact-Activated Lancet Sales by Region (2026-2031) & (K Units)
 Table 38. Asia Pacific Contact-Activated Lancet Revenue by Region (2020-2025) & (US$ Million)
 Table 39. Asia Pacific Contact-Activated Lancet Revenue by Region (2026-2031) & (US$ Million)
 Table 40. Latin America Contact-Activated Lancet Revenue by Country: 2020 VS 2024 VS 2031 (US$ Million)
 Table 41. Latin America Contact-Activated Lancet Sales by Country (2020-2025) & (K Units)
 Table 42. Latin America Contact-Activated Lancet Sales by Country (2026-2031) & (K Units)
 Table 43. Latin America Contact-Activated Lancet Revenue by Country (2020-2025) & (US$ Million)
 Table 44. Latin America Contact-Activated Lancet Revenue by Country (2026-2031) & (US$ Million)
 Table 45. Middle East and Africa Contact-Activated Lancet Revenue by Country: 2020 VS 2024 VS 2031 (US$ Million)
 Table 46. Middle East and Africa Contact-Activated Lancet Sales by Country (2020-2025) & (K Units)
 Table 47. Middle East and Africa Contact-Activated Lancet Sales by Country (2026-2031) & (K Units)
 Table 48. Middle East and Africa Contact-Activated Lancet Revenue by Country (2020-2025) & (US$ Million)
 Table 49. Middle East and Africa Contact-Activated Lancet Revenue by Country (2026-2031) & (US$ Million)
 Table 50. Global Contact-Activated Lancet Sales (K Units) by Type (2020-2025)
 Table 51. Global Contact-Activated Lancet Sales (K Units) by Type (2026-2031)
 Table 52. Global Contact-Activated Lancet Sales Market Share by Type (2020-2025)
 Table 53. Global Contact-Activated Lancet Sales Market Share by Type (2026-2031)
 Table 54. Global Contact-Activated Lancet Revenue (US$ Million) by Type (2020-2025)
 Table 55. Global Contact-Activated Lancet Revenue (US$ Million) by Type (2026-2031)
 Table 56. Global Contact-Activated Lancet Revenue Market Share by Type (2020-2025)
 Table 57. Global Contact-Activated Lancet Revenue Market Share by Type (2026-2031)
 Table 58. Global Contact-Activated Lancet Price (US$/Unit) by Type (2020-2025)
 Table 59. Global Contact-Activated Lancet Price (US$/Unit) by Type (2026-2031)
 Table 60. Global Contact-Activated Lancet Sales (K Units) by Application (2020-2025)
 Table 61. Global Contact-Activated Lancet Sales (K Units) by Application (2026-2031)
 Table 62. Global Contact-Activated Lancet Sales Market Share by Application (2020-2025)
 Table 63. Global Contact-Activated Lancet Sales Market Share by Application (2026-2031)
 Table 64. Global Contact-Activated Lancet Revenue (US$ Million) by Application (2020-2025)
 Table 65. Global Contact-Activated Lancet Revenue (US$ Million) by Application (2026-2031)
 Table 66. Global Contact-Activated Lancet Revenue Market Share by Application (2020-2025)
 Table 67. Global Contact-Activated Lancet Revenue Market Share by Application (2026-2031)
 Table 68. Global Contact-Activated Lancet Price (US$/Unit) by Application (2020-2025)
 Table 69. Global Contact-Activated Lancet Price (US$/Unit) by Application (2026-2031)
 Table 70. BD Company Information
 Table 71. BD Description and Business Overview
 Table 72. BD Contact-Activated Lancet Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2020-2025)
 Table 73. BD Contact-Activated Lancet Product
 Table 74. BD Recent Developments/Updates
 Table 75. Accu-Chek (Roche) Company Information
 Table 76. Accu-Chek (Roche) Description and Business Overview
 Table 77. Accu-Chek (Roche) Contact-Activated Lancet Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2020-2025)
 Table 78. Accu-Chek (Roche) Contact-Activated Lancet Product
 Table 79. Accu-Chek (Roche) Recent Developments/Updates
 Table 80. OneTouch (LifeScan) Company Information
 Table 81. OneTouch (LifeScan) Description and Business Overview
 Table 82. OneTouch (LifeScan) Contact-Activated Lancet Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2020-2025)
 Table 83. OneTouch (LifeScan) Contact-Activated Lancet Product
 Table 84. OneTouch (LifeScan) Recent Developments/Updates
 Table 85. FreeStyle (Abbott) Company Information
 Table 86. FreeStyle (Abbott) Description and Business Overview
 Table 87. FreeStyle (Abbott) Contact-Activated Lancet Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2020-2025)
 Table 88. FreeStyle (Abbott) Contact-Activated Lancet Product
 Table 89. FreeStyle (Abbott) Recent Developments/Updates
 Table 90. Microlet Next (Ascensia) Company Information
 Table 91. Microlet Next (Ascensia) Description and Business Overview
 Table 92. Microlet Next (Ascensia) Contact-Activated Lancet Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2020-2025)
 Table 93. Microlet Next (Ascensia) Contact-Activated Lancet Product
 Table 94. Microlet Next (Ascensia) Recent Developments/Updates
 Table 95. Terumo Company Information
 Table 96. Terumo Description and Business Overview
 Table 97. Terumo Contact-Activated Lancet Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2020-2025)
 Table 98. Terumo Contact-Activated Lancet Product
 Table 99. Terumo Recent Developments/Updates
 Table 100. Genteel Company Information
 Table 101. Genteel Description and Business Overview
 Table 102. Genteel Contact-Activated Lancet Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2020-2025)
 Table 103. Genteel Contact-Activated Lancet Product
 Table 104. Genteel Recent Developments/Updates
 Table 105. CareTouch Company Information
 Table 106. CareTouch Description and Business Overview
 Table 107. CareTouch Contact-Activated Lancet Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2020-2025)
 Table 108. CareTouch Contact-Activated Lancet Product
 Table 109. CareTouch Recent Developments/Updates
 Table 110. Pip Diabetes Care Company Information
 Table 111. Pip Diabetes Care Description and Business Overview
 Table 112. Pip Diabetes Care Contact-Activated Lancet Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2020-2025)
 Table 113. Pip Diabetes Care Contact-Activated Lancet Product
 Table 114. Pip Diabetes Care Recent Developments/Updates
 Table 115. Owen Mumford Company Information
 Table 116. Owen Mumford Description and Business Overview
 Table 117. Owen Mumford Contact-Activated Lancet Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2020-2025)
 Table 118. Owen Mumford Contact-Activated Lancet Product
 Table 119. Owen Mumford Recent Developments/Updates
 Table 120. Trividia Health Company Information
 Table 121. Trividia Health Description and Business Overview
 Table 122. Trividia Health Contact-Activated Lancet Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2020-2025)
 Table 123. Trividia Health Contact-Activated Lancet Product
 Table 124. Trividia Health Recent Developments/Updates
 Table 125. AUVON Company Information
 Table 126. AUVON Description and Business Overview
 Table 127. AUVON Contact-Activated Lancet Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2020-2025)
 Table 128. AUVON Contact-Activated Lancet Product
 Table 129. AUVON Recent Developments/Updates
 Table 130. Key Raw Materials Lists
 Table 131. Raw Materials Key Suppliers Lists
 Table 132. Contact-Activated Lancet Distributors List
 Table 133. Contact-Activated Lancet Customers List
 Table 134. Contact-Activated Lancet Market Trends
 Table 135. Contact-Activated Lancet Market Drivers
 Table 136. Contact-Activated Lancet Market Challenges
 Table 137. Contact-Activated Lancet Market Restraints
 Table 138. Research Programs/Design for This Report
 Table 139. Key Data Information from Secondary Sources
 Table 140. Key Data Information from Primary Sources
 Table 141. Authors List of This Report


List of Figures
 Figure 1. Product Picture of Contact-Activated Lancet
 Figure 2. Global Contact-Activated Lancet Market Value Comparison by Type (2020-2031) & (US$ Million)
 Figure 3. Global Contact-Activated Lancet Market Share by Type: 2024 & 2031
 Figure 4. Below 30G Product Picture
 Figure 5. Above 30G Product Picture
 Figure 6. Global Contact-Activated Lancet Market Value by Application (2020-2031) & (US$ Million)
 Figure 7. Global Contact-Activated Lancet Market Share by Application: 2024 & 2031
 Figure 8. Hospital
 Figure 9. Clinic
 Figure 10. Others
 Figure 11. Global Contact-Activated Lancet Revenue, (US$ Million), 2020 VS 2024 VS 2031
 Figure 12. Global Contact-Activated Lancet Market Size (2020-2031) & (US$ Million)
 Figure 13. Global Contact-Activated Lancet Sales (2020-2031) & (K Units)
 Figure 14. Global Contact-Activated Lancet Average Price (US$/Unit) & (2020-2031)
 Figure 15. Contact-Activated Lancet Report Years Considered
 Figure 16. Contact-Activated Lancet Sales Share by Manufacturers in 2024
 Figure 17. Global Contact-Activated Lancet Revenue Share by Manufacturers in 2024
 Figure 18. Global 5 and 10 Largest Contact-Activated Lancet Players: Market Share by Revenue in Contact-Activated Lancet in 2024
 Figure 19. Contact-Activated Lancet Market Share by Company Type (Tier 1, Tier 2, and Tier 3): 2020 VS 2024
 Figure 20. Global Contact-Activated Lancet Market Size by Region (US$ Million): 2020 VS 2024 VS 2031
 Figure 21. North America Contact-Activated Lancet Sales Market Share by Country (2020-2031)
 Figure 22. North America Contact-Activated Lancet Revenue Market Share by Country (2020-2031)
 Figure 23. United States Contact-Activated Lancet Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 24. Canada Contact-Activated Lancet Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 25. Europe Contact-Activated Lancet Sales Market Share by Country (2020-2031)
 Figure 26. Europe Contact-Activated Lancet Revenue Market Share by Country (2020-2031)
 Figure 27. Germany Contact-Activated Lancet Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 28. France Contact-Activated Lancet Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 29. U.K. Contact-Activated Lancet Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 30. Italy Contact-Activated Lancet Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 31. Russia Contact-Activated Lancet Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 32. Asia Pacific Contact-Activated Lancet Sales Market Share by Region (2020-2031)
 Figure 33. Asia Pacific Contact-Activated Lancet Revenue Market Share by Region (2020-2031)
 Figure 34. China Contact-Activated Lancet Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 35. Japan Contact-Activated Lancet Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 36. South Korea Contact-Activated Lancet Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 37. India Contact-Activated Lancet Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 38. Australia Contact-Activated Lancet Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 39. China Taiwan Contact-Activated Lancet Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 40. Southeast Asia Contact-Activated Lancet Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 41. Latin America Contact-Activated Lancet Sales Market Share by Country (2020-2031)
 Figure 42. Latin America Contact-Activated Lancet Revenue Market Share by Country (2020-2031)
 Figure 43. Mexico Contact-Activated Lancet Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 44. Brazil Contact-Activated Lancet Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 45. Argentina Contact-Activated Lancet Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 46. Middle East and Africa Contact-Activated Lancet Sales Market Share by Country (2020-2031)
 Figure 47. Middle East and Africa Contact-Activated Lancet Revenue Market Share by Country (2020-2031)
 Figure 48. Turkey Contact-Activated Lancet Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 49. Saudi Arabia Contact-Activated Lancet Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 50. UAE Contact-Activated Lancet Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 51. Global Sales Market Share of Contact-Activated Lancet by Type (2020-2031)
 Figure 52. Global Revenue Market Share of Contact-Activated Lancet by Type (2020-2031)
 Figure 53. Global Contact-Activated Lancet Price (US$/Unit) by Type (2020-2031)
 Figure 54. Global Sales Market Share of Contact-Activated Lancet by Application (2020-2031)
 Figure 55. Global Revenue Market Share of Contact-Activated Lancet by Application (2020-2031)
 Figure 56. Global Contact-Activated Lancet Price (US$/Unit) by Application (2020-2031)
 Figure 57. Contact-Activated Lancet Value Chain
 Figure 58. Channels of Distribution (Direct Vs Distribution)
 Figure 59. Bottom-up and Top-down Approaches for This Report
 Figure 60. Data Triangulation
 Figure 61. Key Executives Interviewed
SELECT A FORMAT
Added to Cart
Electronic (PDF)

$2900

This license allows only one user to access the PDF.
Electronic (PDF)

$4350

This license allows 1 - 5 user to access the PDF, license is suitable for small groups of 5 users working together
Electronic (PDF)

$5800

This license allows users/teams in a same Enterprise to use this report, various departments within an enterpise can use this report
Add to Cart
Buy Now (15% Discount)

OUR CUSTOMER

Strategic Venue Partners

RELATED REPORTS

Global Organic Zinc Supplements Market Research Report 2025

120 Pages
Type: Report
Code: QYRE-Auto-38U19850
Wed Dec 03 00:00:00 UTC 2025

Add to Cart

Global Egg Protein Hydrolysates Market Research Report 2025

120 Pages
Type: Report
Code: QYRE-Auto-0Z20517
Wed Dec 03 00:00:00 UTC 2025

Add to Cart

Global PAC Flocculant Dosing Device Market Research Report 2025

120 Pages
Type: Report
Code: QYRE-Auto-28R19905
Wed Dec 03 00:00:00 UTC 2025

Add to Cart

Global Polyaspartic Acid Magnesium Salt(PASP-Mg) Market Research Report 2025

120 Pages
Type: Report
Code: QYRE-Auto-17G20275
Wed Dec 03 00:00:00 UTC 2025

Add to Cart